Manforce rated as no. 1 drug by ORG-IMS Survey

Company Release

New Delhi, January 6

Mankind Pharma, is one of the fastest growing pharmaceutical companies in India. Mankind’s brand Manforce, the drug for erectile dysfunction has been rated ORG-IMS no 1 based on Oct 2005 survey in the respective segment. Launched in 2001, over 8 crore tablets of Manforce have been sold so far. Manforce occupies topmost slot among all brands of Silidenafil Tablets in India and its efficacy can be demonstrated by the fact of its growth at about 40% per year.

According to a survey, it is estimated that about 10% of males in India suffer with Erectile Dysfunction (ED) syndrome. Because of the continual changes in the lifestyles, the number is increasing. As per ORG-IMS audit dated Oct’2005, the total market for ED related drugs in India is about 95 Crore with a yearly growth of 9%. Sildenafil citrate is the only scientifically proven molecule for treatment of ED. Any Silidenafil Tablet manufactured after careful formulation development and high standards of quality is the same in efficacy whether manufactured indigenously or overseas.

Manforce in this category has received tremendous response and have been rated as the no 1 brand in the segment. Also the brand is affordably priced at Rs19/- per tablet of 50mg.

According to Mr. R.C. Juneja, Managing Director, Mankind Pharma. “Mankind has been achieving the growth rate of 60% year after year and to add another feather in the cap is the ORG-IMS ranking of No.1 for its brand Manforce in the ED segment. This clearly indicates that Mankind and its brands are to reckon with in the Indian pharmaceutical market. In future to come our efforts will be focused on delivering and maintaining such standards”

For Further Information please contact:

Bhawna Singh

Corporate Voice|Weber Shandwick Pvt. Ltd.

212, 2nd Floor, Okhla Industrial Estate

Phase - III, New Delhi - 110 020 INDIA

Tel : +91-11-2693 6834 / 35